Compare MRK & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | FOXX |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 34.0M |
| IPO Year | 1994 | N/A |
| Metric | MRK | FOXX |
|---|---|---|
| Price | $119.75 | $4.26 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $123.67 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 9.3K |
| Earning Date | 04-30-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.86% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $16.34 | ★ N/A |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $75.40 | $1.71 |
| 52 Week High | $125.14 | $8.70 |
| Indicator | MRK | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 48.50 |
| Support Level | $113.27 | $4.25 |
| Resistance Level | $125.14 | $4.83 |
| Average True Range (ATR) | 2.18 | 0.32 |
| MACD | 0.25 | 0.03 |
| Stochastic Oscillator | 81.80 | 49.03 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.